MACK GENE (Chief Financial Officer) purchased 14.40K shares of GAIN THERAPEUTICS, INC. on the open market
Open‑market purchase worth $14.5K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/12/2024ACC: 0001493152-24-031378
Officer· Chief Financial Officer
Since Apr 2024
+14.40K
Net shares
Net buyer
$14.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
14.40K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+14.40K
Price / share
$1.01
Trade value
$14.54K
% of position
New position
8/9/2024
0.00→14.40K
Total
Net shares
+14.40K
Net value
$14.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/9/2024 | P · Purchase | +14.40K | $1.01 | $14.54K | New position | 0.00 | 14.40K |
| Total | +14.40K | $14.54K | ||||||
Derivative Transactions0
No derivative transactions reported